Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease

Alzheimer’s disease (AD) is the most common cause of dementia among older people. There are no effective medications currently available to prevent and treat AD and halt disease progression. Monoacylglycerol lipase (MAGL) is the primary enzyme metabolizing the endocannabinoid 2-arachidonoylglycerol...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Chen, Rongqing, Zhang, Jian, Wu, Yan, Wang, Dongqing, Feng, Guoping, Tang, Ya-Ping, Teng, Zhaoqian, Chen, Chu
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2012
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
https://ncbi.nlm.nih.gov/pubmed/23122958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2012.09.030
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi